Skip to search formSkip to main contentSkip to account menu

F15063

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
RationaleThere is increasing interest in antipsychotics intended to manage positive symptoms via D2 receptor blockade and improve… 
2008
2008
Interaction at dopamine D4 receptors may improve cognitive function, which is highly impaired in individuals with schizophrenia… 
Review
2008
Highly Cited
2007
Highly Cited
2007
The D2/D3 receptor antagonist, D4 receptor partial agonist, and high efficacy 5‐HT1A receptor agonist F15063 was shown to be… 
2007
2007
F15063 is a high affinity D2/D3 antagonist, D4 partial agonist, and high efficacy 5‐HT1A agonist, with little affinity (40‐fold… 
2007
2007
Combining 5‐HT1A receptor activation with dopamine D2/D3 receptor blockade should improve negative symptoms and cognitive… 
2007
2007
F15063 (N-[(2,2-dimethyl-2,3-dihydro-benzofuran-7-yloxy)ethyl]-3-(cyclopent-1-enyl)-benzylamine fumarate salt) is a novel…